Global Medicines for Eosinophilic Asthma Treatment Market Research Report 2023

Report ID: 1746858 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Drug Delivery Method
        1.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Drug Delivery Method: 2017 VS 2021 VS 2028
        1.2.2 Intravenous Infusion
        1.2.3 Subcutaneous Injection
    1.3 Market by Application
        1.3.1 Global Medicines for Eosinophilic Asthma Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Children
        1.3.3 Adults
        1.3.4 Teenagers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Medicines for Eosinophilic Asthma Treatment Market Perspective (2017-2028)
    2.2 Medicines for Eosinophilic Asthma Treatment Growth Trends by Region
        2.2.1 Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Medicines for Eosinophilic Asthma Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Medicines for Eosinophilic Asthma Treatment Market Dynamics
        2.3.1 Medicines for Eosinophilic Asthma Treatment Industry Trends
        2.3.2 Medicines for Eosinophilic Asthma Treatment Market Drivers
        2.3.3 Medicines for Eosinophilic Asthma Treatment Market Challenges
        2.3.4 Medicines for Eosinophilic Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue
        3.1.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue (2017-2022)
        3.1.2 Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Medicines for Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Medicines for Eosinophilic Asthma Treatment Revenue
    3.4 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio
        3.4.1 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Medicines for Eosinophilic Asthma Treatment Revenue in 2021
    3.5 Medicines for Eosinophilic Asthma Treatment Key Players Head office and Area Served
    3.6 Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
    3.7 Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Drug Delivery Method
    4.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Drug Delivery Method (2017-2022)
    4.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Drug Delivery Method (2023-2028)
5 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Application
    5.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
    6.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
    6.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
    7.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
    7.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
    9.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
    9.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Medicines for Eosinophilic Asthma Treatment Introduction
        11.1.4 AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
        11.1.5 AstraZeneca Recent Development
    11.2 GSK
        11.2.1 GSK Company Detail
        11.2.2 GSK Business Overview
        11.2.3 GSK Medicines for Eosinophilic Asthma Treatment Introduction
        11.2.4 GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
        11.2.5 GSK Recent Development
    11.3 Genentech (Roche Group) & Novartis
        11.3.1 Genentech (Roche Group) & Novartis Company Detail
        11.3.2 Genentech (Roche Group) & Novartis Business Overview
        11.3.3 Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Introduction
        11.3.4 Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
        11.3.5 Genentech (Roche Group) & Novartis Recent Development
    11.4 Regeneron Pharmaceuticals & Sanofi
        11.4.1 Regeneron Pharmaceuticals & Sanofi Company Detail
        11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
        11.4.3 Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Introduction
        11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
        11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Development
    11.5 Teva Pharmaceuticals
        11.5.1 Teva Pharmaceuticals Company Detail
        11.5.2 Teva Pharmaceuticals Business Overview
        11.5.3 Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Introduction
        11.5.4 Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
        11.5.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Drug Delivery Method (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous Infusion
    Table 3. Key Players of Subcutaneous Injection
    Table 4. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2017-2022)
    Table 8. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2023-2028)
    Table 10. Medicines for Eosinophilic Asthma Treatment Market Trends
    Table 11. Medicines for Eosinophilic Asthma Treatment Market Drivers
    Table 12. Medicines for Eosinophilic Asthma Treatment Market Challenges
    Table 13. Medicines for Eosinophilic Asthma Treatment Market Restraints
    Table 14. Global Medicines for Eosinophilic Asthma Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2021)
    Table 17. Ranking of Global Top Medicines for Eosinophilic Asthma Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
    Table 21. Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022) & (US$ Million)
    Table 24. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Drug Delivery Method (2017-2022)
    Table 25. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Drug Delivery Method (2023-2028) & (US$ Million)
    Table 26. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Drug Delivery Method (2023-2028)
    Table 27. Global Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. AstraZeneca Company Detail
    Table 42. AstraZeneca Business Overview
    Table 43. AstraZeneca Medicines for Eosinophilic Asthma Treatment Product
    Table 44. AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022) & (US$ Million)
    Table 45. AstraZeneca Recent Development
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK Medicines for Eosinophilic Asthma Treatment Product
    Table 49. GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Genentech (Roche Group) & Novartis Company Detail
    Table 52. Genentech (Roche Group) & Novartis Business Overview
    Table 53. Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Product
    Table 54. Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022) & (US$ Million)
    Table 55. Genentech (Roche Group) & Novartis Recent Development
    Table 56. Regeneron Pharmaceuticals & Sanofi Company Detail
    Table 57. Regeneron Pharmaceuticals & Sanofi Business Overview
    Table 58. Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Product
    Table 59. Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022) & (US$ Million)
    Table 60. Regeneron Pharmaceuticals & Sanofi Recent Development
    Table 61. Teva Pharmaceuticals Company Detail
    Table 62. Teva Pharmaceuticals Business Overview
    Table 63. Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Product
    Table 64. Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022) & (US$ Million)
    Table 65. Teva Pharmaceuticals Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method: 2021 VS 2028
    Figure 2. Intravenous Infusion Features
    Figure 3. Subcutaneous Injection Features
    Figure 4. Global Medicines for Eosinophilic Asthma Treatment Market Share by Application in 2021 & 2028
    Figure 5. Children Case Studies
    Figure 6. Adults Case Studies
    Figure 7. Teenagers Case Studies
    Figure 8. Medicines for Eosinophilic Asthma Treatment Report Years Considered
    Figure 9. Global Medicines for Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Medicines for Eosinophilic Asthma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players in 2021
    Figure 13. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue in 2021
    Figure 15. North America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2017-2028)
    Figure 17. United States Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Share by Region (2017-2028)
    Figure 29. China Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. AstraZeneca Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
    Figure 44. GSK Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
    Figure 45. Genentech (Roche Group) & Novartis Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
    Figure 46. Regeneron Pharmaceuticals & Sanofi Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
    Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
GSK
Genentech (Roche Group) & Novartis
Regeneron Pharmaceuticals & Sanofi
Teva Pharmaceuticals
Frequently Asked Questions
Medicines for Eosinophilic Asthma Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Medicines for Eosinophilic Asthma Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Medicines for Eosinophilic Asthma Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports